WHAT:New data shows vitamin E supplements boost the risk of prostate cancer by 17 percent
WHEN: 4 p.m. Wednesday, October 12, 2011
WHERE: Cancer Therapy & Research Center at The University of Texas Health Science Center, 7979 Wurzbach, 4th Floor Grossman Building, San Antonio
- Ian M. Thompson, Jr., M.D., CTRC director and one of the study’s authors
- Laurence Baker, D.O., study co-author and chairman of SWOG, which led the 35,000-man study
- John Crowley, Ph.D., SWOG statistician
- Study patients will be available for interviews
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.